Showing 5621-5630 of 19383 results for "".
What is Munchausen Syndrome by Proxy (MSP)?
https://reachmd.com/programs/clinicians-roundtable/what-is-munchausen-syndrome-by-proxy-msp/2994/What do we currently know about the factitious disorder, Munchausen syndrome by proxy (MSP)? How is it diagnosed, what are the symptoms, and what treatments are recommended? Host Dr. Shira Johnson speaks with Dr. Lawrence Robbins about this interesting and controversial subject.Why Clinical Skills are Crucial to Early Psoriatic Arthritis Diagnosis
https://reachmd.com/programs/beyond-skin-deep/why-clinical-skills-are-crucial-to-early-psoriatic-arthritis-diagnosis/10147/Detecting PsA isn’t easy, but these essential tips will help sharpen your screening skills so you can make an accurate AND timely diagnosis.Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
https://reachmd.com/programs/eye-on-ocular-health/distinguishing-urgent-vs-monitorable-retinal-vein-occlusion/54484/Retinal vein occlusion can range from mild, monitorable disease to vision-threatening pathology requiring immediate intervention, making early risk stratification essential for preserving sight. Tune in to hear Dr. Ashkan Abbey, Director of Clinical Research at Texas Retina Associates in Dallas, outCan AI Transform How We Diagnose ATTR-CM?
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/can-ai-transform-how-we-diagnose-attr-cm/49039/Artificial intelligence (AI) is reshaping how clinicians identify transthyretin amyloid cardiomyopathy (ATTR-CM), offering new opportunities to improve early recognition and diagnostic accuracy. Joining Ryan Quigley to discuss the evolving non-biopsy diagnostic pathway and the growing role of AI inClinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
https://reachmd.com/programs/advances-in-womens-health/clinical-outcomes-of-radiation-vs-chemoradiation-in-recurrent-endometrial-cancer/37231/The recent NRG0238 trial evaluated whether adding chemotherapy to radiation improves outcomes in patients with localized endometrial cancer recurrences. Hear from Dr. Ann Klopp as she explains the findings and how they could shift practice patterns for patient care. Dr. Klopp is a Professor of RadiaDWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://reachmd.com/series/dermwire-tv/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Menopausal Hormone Therapy for Bone Health: Balancing Benefits and Risks
https://reachmd.com/programs/frontlines-osteoporosis/menopausal-hormone-therapy-for-bone-health-balancing-benefits-and-risks/32333/Emerging data is highlighting the benefits of hormone therapy for preventing fractures and bone loss. Here’s how we can weigh those benefits against its risks.Concerns in the Community: Obstacles to Accessing the COVID-19 Vaccine
https://reachmd.com/programs/clinicians-roundtable/concerns-in-the-community-obstacles-to-accessing-the-covid-19-vaccine/12454/How have healthcare barriers impacted access to the COVID-19 vaccine?Multiple Sclerosis Physician Resources
https://reachmd.com/programs/global-neurology-academy/multiple-sclerosis-physician-resources/9478/This resource provides internet links that may be of interest to your patients diagnosed with multiple schlerosis. Many of these links will provide invaluable information to your patients and will help them understand their diagnosis, cope with symptoms and treatments, and improve their quality of lNew Treatments for Multiple Myeloma
https://reachmd.com/programs/clinicians-roundtable/new-treatments-for-multiple-myeloma/2568/Dr. Shira Johnson welcomes Dr. Brian Durie for a discussion about current diagnostic modalities and therapeutic approaches for multiple myeloma (MM), which have transformed its course into a chronic and often manageable illness.